Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade

开发生理组织模型来评估肿瘤外植体对免疫检查点封锁的反应

基本信息

批准号：
10250392
负责人：
David A Barbie
金额：
$ 82.64万
依托单位：
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-09-30 至 2022-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10250392
关键词：
3-Dimensional Animal Model Antigens Back Basic Science Biological Assay Biological Models Blood Vessels CTLA4 gene Cancer Patient Cell Communication Cell Culture Techniques Cell Proliferation Cell Survival Cell physiology Cells Cellular Structures Chronic Clinical Clinical Trials Combined Modality Therapy Complex Conditioned Culture Media Data Dendritic Cells Development Effector Cell Endothelial Cells Engineering Enrollment Evaluation Evolution Extracellular Matrix Extravasation Fibroblasts Flow Cytometry Gel Goals Growth Growth Factor Human Immune Immune Targeting Immune checkpoint inhibitor Immune response Immunofluorescence Immunologic Immunotherapy In Vitro Investigation Knowledge Malignant Neoplasms Malignant neoplasm of thyroid Measurement Measures Microfluidic Microchips Microfluidics Modeling Monitor Mus Myeloid Cells Organoids PD-1 inhibitors PD-1/PD-L1 Patients Phenotype Physiological Population Primary Neoplasm Protocols documentation Public Health Research Research Project Grants Resistance Running Sampling Side Signal Transduction Specimen Support System System T-Lymphocyte TBK1 gene Techniques Technology Time Tissue Model Translational Research Tumor Biology Tumor Tissue Tumor-Derived Tumor-infiltrating immune cells Validation Vascular System Work anti-CTLA4 anti-CTLA4 antibodies anti-PD-1 anti-PD-1/PD-L1 anti-PD1 antibodies anticancer research base cancer cell cancer immunotherapy cancer type cell growth cell killing cell motility checkpoint therapy chemokine clinical decision-making cytokine diagnostic platform experience experimental study immune activation immune checkpoint immune checkpoint blockade immune function in vivo individual patient inhibitor/antagonist macrophage melanoma monocyte neoplastic cell novel patient response patient subsets physiologic model predicting response predictive marker predictive tools response standard of care targeted treatment trafficking tumor tumor microenvironment

项目摘要

PROJECT SUMMARY The goal of this research project proposal is to develop a physiologic model of ex vivo tumor culture to study responsiveness to immune checkpoint blockade. Although inhibitors of the PD-1/PD-L1 and CTLA4 immune checkpoints have led to remarkable and durable responses in cancers such as malignant melanoma, the ability to predict the activity for individual patients remains limited, and have relied on measurements from fixed tumor tissue. While the ability to grow patient derived tumors in organoid models, for example, has been rigorously demonstrated over the past several years, these systems lack key features of the tumor microenvironment, including a vascular network and immune cells. Thus, an ex vivo system that supports tumor and immune cell culture by recapitulating a physiologic microenvironment will almost certainly be essential to the development of functional assays that can predict patient response to immunotherapy. Recently, we demonstrated that our three-dimensional microfluidic culture system can support growth of primary human tumor spheroids derived from multiple different cancer types, including melanoma. Importantly, immune profiling of the cells within the spheroids reveals that they also contain a significant proportion of tumor associated immune cells, including macrophages, dendritic cells, and antigen experienced T lymphocytes. Exposure of these short term spheroid cultures to immune checkpoint inhibitors such as anti- PD1 antibodies results in evidence of immunologic response and robust cytokine secretion into conditioned medium, as well as evidence of cell killing in some cases. The broad, long term objective of this proposal is to extend this preliminary model to leverage the capabilities developed in our labs to incorporate a microcirculatory network in the 3D matrix surrounding the tumor and use this as a means of subsequently introducing selected myeloid cells. Both the initial model and these extensions to it will be subject to detailed validation in order to develop a realistic physiologic culture system that enables prediction of immunotherapy response. A unique aspect of this work is that it spans basic and translational research, including the use of animal models to help engineer vascularized networks, and patient-derived samples and clinical response to immune checkpoint blockade to validate the system. Specific aims are to: 1) Refine and validate an existing microfluidic tumor culture model to assess response to immune checkpoint inhibitor therapies 2) Incorporate vascular flow of immune cells to monitor extravasation and expansion of immune effector cells in tumor culture, and 3) Directly compare ex vivo experiments with patient specific response to immune checkpoint blockade. Through these complementary studies, the ultimate goal is to develop a robust model that can eventually be adapted to clinical use to help target immune checkpoint inhibitor therapies to the appropriate subgroup of patients. This basic platform will also be useful in other settings, once it has been fully evaluations

项目概要该研究项目提案的目标是开发离体肿瘤培养的生理模型，以研究对免疫检查点封锁的反应。尽管 PD-1/PD-L1 和 CTLA4 抑制剂免疫检查点对恶性黑色素瘤等癌症产生了显着且持久的反应，预测个体患者活动的能力仍然有限，并且依赖于来自固定肿瘤组织。例如，虽然在类器官模型中培养源自患者的肿瘤的能力已经经过过去几年的严格证明，这些系统缺乏肿瘤的关键特征微环境，包括血管网络和免疫细胞。因此，支持的离体系统通过重现生理微环境来进行肿瘤和免疫细胞培养几乎肯定会是对于开发可以预测患者对免疫治疗反应的功能测定至关重要。最近，我们证明了我们的三维微流体培养系统可以支持生长源自多种不同癌症类型（包括黑色素瘤）的原发性人类肿瘤球体。重要的是，球体内细胞的免疫分析表明，它们还含有重要的肿瘤相关免疫细胞（包括巨噬细胞、树突状细胞和抗原）的比例 T淋巴细胞。将这些短期球状培养物暴露于免疫检查点抑制剂，例如抗 PD1 抗体导致免疫反应和强大的细胞因子分泌到条件条件下的证据培养基，以及在某些情况下细胞死亡的证据。该提案的广泛、长期目标是扩展该初步模型以利用我们实验室开发的功能可将微循环网络纳入周围的 3D 矩阵中肿瘤并使用它作为随后引入选定的骨髓细胞的手段。初始模型和这些扩展将受到详细验证，以开发现实的生理培养能够预测免疫治疗反应的系统。这项工作的独特之处在于它涵盖了基础知识和转化研究，包括使用动物模型来帮助设计血管网络，以及患者来源的样本和对免疫检查点封锁的临床反应来验证该系统。具体的目标是：1）完善和验证现有的微流体肿瘤培养模型以评估对免疫的反应检查点抑制剂疗法 2) 结合免疫细胞的血管流动来监测外渗和在肿瘤培养物中扩增免疫效应细胞，以及 3) 直接与患者进行离体实验比较对免疫检查点封锁的特异性反应。通过这些补充研究，最终目标是开发一个最终可以适应临床使用的强大模型，以帮助靶向免疫检查点对适当的患者亚组进行抑制剂治疗。这个基本平台也将在其他方面有用设置，一旦经过充分评估

项目成果

期刊论文数量（18）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

The effects of luminal and trans-endothelial fluid flows on the extravasation and tissue invasion of tumor cells in a 3D in vitro microvascular platform.

DOI：
10.1016/j.biomaterials.2020.120470
发表时间：
2021-01
期刊：
Biomaterials
影响因子：
14
作者：
Hajal C;Ibrahim L;Serrano JC;Offeddu GS;Kamm RD
通讯作者：
Kamm RD

Vascularized organoids on a chip: strategies for engineering organoids with functional vasculature.

DOI：
10.1039/d0lc01186j
发表时间：
2021-02-09
期刊：
Lab on a chip
影响因子：
6.1
作者：
Zhang S;Wan Z;Kamm RD
通讯作者：
Kamm RD

Interstitial flow promotes macrophage polarization toward an M2 phenotype.

DOI：
10.1091/mbc.e18-03-0164
发表时间：
2018-08-08
期刊：
Molecular biology of the cell
影响因子：
3.3
作者：
Li R;Serrano JC;Xing H;Lee TA;Azizgolshani H;Zaman M;Kamm RD
通讯作者：
Kamm RD

Integrated in silico and 3D in vitro model of macrophage migration in response to physical and chemical factors in the tumor microenvironment.

集成巨噬细胞响应肿瘤微环境中的物理和化学因素的计算机模拟和 3D 体外模型。

DOI：
10.1093/intbio/zyaa007
发表时间：
2020
期刊：
Integrative biology : quantitative biosciences from nano to macro
影响因子：
0
作者：
Lee,SharonWeiLing;Seager,RJ;Litvak,Felix;Spill,Fabian;Sieow,JeLin;Leong,PennyHweixian;Kumar,Dillip;Tan,AlrinaShinMin;Wong,SiewCheng;Adriani,Giulia;Zaman,MuhammadHamid;Kamm,AndRogerD
通讯作者：
Kamm,AndRogerD

The effects of monocytes on tumor cell extravasation in a 3D vascularized microfluidic model.